Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» anticoagulants
anticoagulants
Anthos hails win over Xarelto with novel anticoagulant
Pharmaphorum
Mon, 09/18/23 - 09:56 am
Anthos Therapeutics
clinical trials
abelacimab
Xarelto
anticoagulants
atrial fibrillation
Anthos Therapeutics is Developing a Hemostasis-Sparing Anticoagulant to Reduce the Hazard of Bleeding
BioSpace
Thu, 09/10/20 - 11:12 pm
Anthos Therapeutics
anticoagulants
Verseon to Initiate Ph I Study of New Class Anticoagulant with Reduced Bleeding Risk
CP Wire
Thu, 06/14/18 - 09:48 am
Verseon
VE-1902
anticoagulants
Verseon to Initiate Ph I Study of New Class Anticoagulant with Reduced Bleeding Risk
Thu, 06/14/18 - 09:31 am
Verseon
VE-1902
anticoagulants
[video]How Portola Is Looking to Change the Anticoagulant Game
Motley Fool
Tue, 07/11/17 - 09:55 am
Portola Pharmaceuticals
anticoagulants
Bevyxxa
JNJ
Pfizer
Boehringer seeks real-world data to support reversal agent
BioPharma Dive
Thu, 08/18/16 - 08:49 am
Boehringer Ingelheim
Praxbind
Pradaxa
anticoagulants
anticoagulant reversal
3 Healthcare Trends Johnson & Johnson Told Us About This Earnings Season
Motley Fool
Thu, 10/22/15 - 09:59 am
JNJ
earnings
emerging markets
anticoagulants
Bayer fronting $155M for a promising anticoagulant from Isis Pharma
Fierce Biotech
Mon, 05/4/15 - 10:08 am
Bayer
anticoagulants
Isis Pharmaceuticals
ISIS-FXI
antisense
Could This Drug Make Isis Pharmaceuticals Soar?
Investopedia
Thu, 03/12/15 - 10:56 am
Isis Pharmaceuticals
anticoagulants
ISIS-FXIRx
FDA Places Clinical Hold On Phase 3 Trial Of Novel Anticoagulant
Forbes
Thu, 07/10/14 - 03:42 pm
FDA
Regado Biosciences
anticoagulants
Revolixys
Regado Halts Big Heart Drug Trial, Shares Hammered
Motley Fool
Thu, 07/3/14 - 10:37 am
Regado Biosciences
clinical trials
REG1
anticoagulants
FDA Grants New Indication For Pfizer/Bristol Anticoagulant
Forbes
Sat, 03/15/14 - 10:12 am
Pfizer
DVT
Bristol-Myers Squibb
Apixaban
anticoagulants
Eliquis
Bayer rival Boehringer seeks wider use of anti-clotting pill
Reuters
Mon, 06/24/13 - 10:31 am
Bayer
Boehringer Ingelheim
anticoagulants
Pradaxa
deep vein thrombosis
pulmonary embolism
Roller Coaster Path To Approval For Eliquis Uncovered By FDA Documents
Forbes
Fri, 06/21/13 - 08:54 am
Eliquis
FDA
Pfizer
Bristol-Myers Squibb
anticoagulants
Boehringer anti-clotting pill gains blockbuster status
Reuters
Wed, 04/24/13 - 08:47 am
anticoagulants
Boehringer Ingelheim
Pradaxa
Studies Examine Novel Use For New Oral Anticoagulant Drugs Comment Now Follow Comments
Forbes
Thu, 02/21/13 - 11:11 am
anticoagulants
dabigatran
Apixaban
Blood Thinner From Pfizer, Bristol-Myers Blocks Leg Clots
Bloomberg
Sun, 12/9/12 - 11:22 am
Bristol-Myers Squibb
Pfizer
Eliquis
blood thinners
anticoagulants
The Battle For The Anti-Coagulation Market
Seeking Alpha
Thu, 02/23/12 - 11:58 am
anticoagulants
Pfizer
Sanofi
Bristol-Myers Squibb
Study Finds Risk in New Stroke Drug Pradaxa
WSJ Online
Tue, 01/10/12 - 09:30 am
Pradaxa
stroke
anticoagulants
Boehringer Ingelheim
Apixaban- Pfizer's Multi-Billion Dollar Income Replacement For Lipitor
Seeking Alpha
Sat, 12/10/11 - 12:48 pm
Apixaban
Pfizer
anticoagulants
Pages
1
2
next ›
last »